Clinical Trial Update: An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray. [Phase 2]

View source ↗

Summary

This open-label Phase 2 study assessed the safety and tolerability of chronic intermittent diazepam nasal spray in epilepsy, and the trial was terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Diazepam nasal spray (diazepam)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Epilepsy | Phase 2 | Status: TERMINATED | Results posted: 2018-07-30